QINLOCK Trademark

Trademark Overview


On Tuesday, November 5, 2019, a trademark application was filed for QINLOCK with the United States Patent and Trademark Office. The USPTO has given the QINLOCK trademark a serial number of 88680329. The federal status of this trademark filing is REGISTERED as of Tuesday, September 29, 2020. This trademark is owned by Deciphera Pharmaceuticals, LLC. The QINLOCK trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma

medical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
qinlock

General Information


Serial Number88680329
Word MarkQINLOCK
Filing DateTuesday, November 5, 2019
Status700 - REGISTERED
Status DateTuesday, September 29, 2020
Registration Number6165744
Registration DateTuesday, September 29, 2020
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 12, 2020

Trademark Statements


Description of MarkThe mark consists of the word "QINLOCK" in the color purple with the "O" forming a lock design in the colors gold and white.
Goods and Servicespharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
Indication of Colors claimedThe color(s) purple, gold and white is/are claimed as a feature of the mark.
Goods and Servicesmedical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, November 9, 2019
Primary Code005
First Use Anywhere DateSaturday, May 16, 2020
First Use In Commerce DateWednesday, May 20, 2020

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 26, 2020
Primary Code044
First Use Anywhere DateSaturday, May 16, 2020
First Use In Commerce DateWednesday, May 20, 2020

Trademark Owner History


Party NameDeciphera Pharmaceuticals, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWaltham, MA 02451

Party NameDeciphera Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWaltham, MA 02451

Party NameDeciphera Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWaltham, MA 02451

Trademark Events


Event DateEvent Description
Friday, November 8, 2019NEW APPLICATION ENTERED
Saturday, November 9, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 12, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, February 10, 2020ASSIGNED TO EXAMINER
Friday, March 27, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 13, 2020NON-FINAL ACTION WRITTEN
Thursday, February 13, 2020NON-FINAL ACTION E-MAILED
Thursday, February 13, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 26, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 26, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 26, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 12, 2020PUBLISHED FOR OPPOSITION
Tuesday, May 12, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, July 27, 2020TEAS STATEMENT OF USE RECEIVED
Monday, July 27, 2020USE AMENDMENT FILED
Tuesday, July 7, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 27, 2020SOU TEAS EXTENSION RECEIVED
Monday, July 27, 2020SOU EXTENSION 1 FILED
Wednesday, August 12, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 12, 2020SOU EXTENSION 1 GRANTED
Wednesday, August 12, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 24, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 25, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 29, 2020REGISTERED-PRINCIPAL REGISTER
Monday, September 29, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED